MeSH tree: C06.552.380
Chronic hepatitis B is substantially prevalent across the European Union and European Economic Area (EU/EEA), affecting an estimated 0.7% of the population in the region in 2022, according to a new study published in Eurosurveillance. ...
Apr 13, 2026
0
1
A Stanford study shows that jail-based hepatitis C programs could cut new infections by nearly half among people who inject drugs, potentially providing a major boost to lagging U.S. efforts to meet national hepatitis C elimination ...
Mar 30, 2026
0
4
Direct-acting antivirals (DAAs) can cure hepatitis C (HCV) in more than 95% of individuals treated. But only 1 in 3 people with HCV in the U.S. receive treatment within a year of diagnosis. A new study by investigators from ...
Mar 25, 2026
0
3
A recently released prospective analysis of the first eight years of the Johns Hopkins Medicine-led Zero TB in Kids program shows that significant reduction of tuberculosis (TB) transmission and burden (the total impact of ...
Mar 24, 2026
0
3
Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and hepatocellular cancer (HCC, liver cancer). It affects approximately 296 million people worldwide. Hepatitis ...
Mar 2, 2026
0
7
It sounds like something from a science fiction novel, but Alabama officials' plan to use robots to improve care for rural pregnant women and their babies is real. During a January White House roundtable touting the first ...
Feb 18, 2026
0
4
Hepatitis B vaccination at birth is safe and effective compared with a delayed first dose, according to research published online Feb. 5 in Pediatrics.
Feb 11, 2026
0
4
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis and treatment in hard-to-reach ...
Feb 8, 2026
0
11
A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face substantially higher risks of kidney dysfunction than those living with HIV alone.
Jan 14, 2026
0
10
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.
Jan 13, 2026
0
21
